Millions of children and young people worldwide experience significant adversity. In turn, a history of childhood adversity predicts elevated risk of mental and physical illness. Because of the large health burden associated with childhood adversity, a better understanding of the mechanisms through which children's psychosocial stress 'gets under the skin' and is translated into biological risk for disease, or biological embedding (Danese & McEwen, 2012) , is a top research priority. The review by Koss and Gunnar (2018) provides a scholarly overview of the role of the hypothalamic-pituitary-adrenal (HPA) axis in mediating the association between childhood adversity and psychopathology.
The mediating role of the HPA axis is predicted based on separate evidence for the association of early life stress with abnormal HPA axis functioning on the one hand, and the association of abnormal HPA axis functioning with health outcomes on the other. First, over the past 60 years experimental research in rodents and non-human primates has shown that manipulation of the early rearing environment can result in multiple neuroendocrine abnormalities. Similarly, Koss and Gunnar (2018) argue that neuroendocrine abnormalities, such as low peripheral cortisol levels, are also often observed in children exposed to adversity. As in animal models of early life stress, findings on cortisol levels in children exposed to adversity are heterogeneous and appear to vary based on the broader social context children live in, the emotional/behavioural abnormalities observed at the time of cortisol assessment, and possibly the age at which children experienced adversity. The authors recommend that future studies should employ more standardised and systematic protocols for HPA axis assessment, in order to minimise methodological variation across studies, reduce file-drawer effects, and obtain a more comprehensive understanding of HPA axis abnormalities in humans. Second, disruption in HPA axis functioning can lead to emotional and behavioural abnormalities. Koss and Gunnar (2018) discuss key neuroendocrine correlates of child psychopathology, both describing the general factshigh cortisol levels in depressed and anxious children and low cortisol levels in children with PTSD and externalising disorders -and openly reflecting on the many inconsistencies.
But what can this fragmented evidence tell us about the potential neuroendocrine mediation of the association between childhood adversity and psychopathology? Koss and Gunnar's (2018) insightful observations build a rich framework to critically appraise the current evidence and inform future research in this area.
The authors focus on studies of children. Over the past two decades, researchers have been enticed into undertaking research on the biological sequelae of early life stress in samples of adults. By asking adults to retrospectively recall their childhood experiences and simultaneously collecting biological samples, researchers could avoid several of the ethical and practical challenges that emerge when working with children. However, the cross-sectional design used in studies of adults does not provide the temporal separation between exposure, potential mediator, and outcome that is needed to correctly specify mediation models (MacKinnon, Fairchild, & Fritz, 2007) . In particular, the cross-sectional design makes it impossible to test alternative hypotheses about the direction of effects: Does adversity precede or follow abnormal HPA axis functioning? Does abnormal HPA axis functioning precede or follow psychopathology? These hypotheses need to be directly tested because empirical findings from longitudinal research may deviate from developmental theories built on cross-sectional data. For example, cross-sectional findings of cognitive deficits in adults reporting a history of childhood adversity have been often interpreted to suggest that childhood adversity leads to later cognitive deficits. In contrast, longitudinal studies showed that, although victimised children do have cognitive deficits in adolescence and adulthood, these are largely explained by cognitive deficits measured prior to victimisation exposure in childhood . More longitudinal studies of children are needed to understand mechanisms of biological embedding.
The authors highlight measurement issues. Indeed, the quality of an explanatory model can only be as good as the quality (i.e., reliability, validity) of the measures used for its development. With regard to childhood adversity, commonly used retrospective measures often have adequate intra-rater reliability. However, there is increasing appreciation that reliance on retrospective recall may be flawed because prospective and retrospective measures of childhood adversity identify only partly overlapping groups of individuals (Reuben et al., 2016) . As such, mediation pathways linking retrospective measures of childhood adversity to psychopathology may differ from mediation pathways relevant to prospective measures. Furthermore, it is possible that different pathways might link different types of adversity to psychopathology (McLaughlin & Sheridan, 2016) . With regard to HPA axis, because of circadian variation in cortisol levels, the review underscores the need to employ either time-sensitive, standardised methods (e.g. Cortisol Awakening Response) or average hormonal outputs -ideally over multiple days -in order to maximise reliability. The collection of valid measures of HPA axis abnormalities is also challenging. As negative health consequences are thought to arise from chronic or repeated activation of the HPA axis (Danese & McEwen, 2012) , cortisol samples collected at a single follow-up assessment may not adequately capture the intended construct. Alternatively, if negative health consequences are hypothesised to arise because of HPA axis activation during a specific developmental phase in early life (Danese & McEwen, 2012) , then sample collection should be timed accordingly.
The authors emphasise the use of statistical models of mediation. To directly test biological mediation of the association between childhood adversity and psychopathology, studies need to combine measures of exposure, potential mediator, and outcome in the same individuals (MacKinnon et al., 2007) . This is because there are large individual differences in psychopathological and neuroendocrine outcomes after childhood adversity. Likewise, there are large individual differences in psychopathological outcomes among those with neuroendocrine abnormalities. Therefore, assumptions about the overlap between at-risk groups based on fragmented evidence from separate studies may be unwarranted. Researchers exploring mediation pathways need to directly test whether victimised children who develop HPA axis abnormalities in adolescence are the same adolescents with abnormal HPA axis functioning who develop psychopathology later in life. Successful examples of mediation models (Koss, Mliner, Donzella, & Gunnar, 2016) need to stimulate further research in the field.
The authors point to the limits of causal inference. Indeed, evidence of statistical mediation is only the first step to explore causal pathways linking childhood adversity and later clinical outcomes (MacKinnon et al., 2007) . As children are, of course, not randomly exposed to adversity, children who do or do not experience adversity may differ in pre-existing individual, family, or community characteristics, which in turn could affect HPA axis functioning. Similarly, HPA axis abnormalities do not occur in isolation, and correlated biological abnormalities might explain the apparent association between HPA axis and psychopathology. These alternative explanations need to be tested directly to inform causal inference. For example, better characterisation of potential confounding factors can inform the development of more comprehensive statistical models in observational human studies. Furthermore, animal models where initially exposure to early life stress is experimentally manipulated and then the hypothesised mediation pathway is targeted through pharmacological intervention can elucidate causal effects within those models. Although no single design can fully address causal inference in humans, cumulative evidence from multiple approaches can progressively clarify causal effects within mediation pathways.
Finally, while focusing on the HPA axis for their review, the authors call for broad mapping of multiple biological pathways linking childhood adversity and later psychopathology. As psychopathology is driven by abnormal brain functioning, it is important to identify early brain-functioning abnormalities that predict later psychopathology in children who experienced adversity (McCrory, Gerin, & Viding, 2017) . Furthermore, over the past decade research has shown that childhood adversity is associated with high inflammation levels, which in turn can affect brain development and later risk for psychopathology (Danese & Baldwin, 2017) . Of note, investigations in neuroendocrinology, neuroimaging, and neuroimmunology face many of the same challenges. These similarities emphasise the need for a new generation of studies testing biological embedding hypotheses with greater attention to design, measurement, statistical models, and translational approaches.
Research has made tremendous progress in generating hypotheses on plausible biological mechanisms linking childhood adversity and psychopathology. Rigorous test of these hypothesised mechanisms is now needed to maximise their clinical potential. We must rise to this challenge because considerable reward is in sight: by uncovering the causal pathways underlying the biological embedding of childhood adversity, we can identify important new targets to prevent the most impairing forms of psychopathology among the most vulnerable individuals in society.
